drugset / Trial / NCT00644488
A Phase I Study of BMS-641988 in Japanese Patients With Castration Resistant Prostate Cancer
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this clinical study is to assess the safety and tolerability of BMS-641988 once daily orally in Japanese patients with castration resistant prostate cancer
Timeline
- Start
- 2008-07
- Primary completion
- 2009-03
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-641988 | Unknown | 20 mg | Oral |
| Subject | BMS-641988 | Unknown | 40 mg | Oral |
| Subject | BMS-641988 | Unknown | 60 mg | Oral |
| Subject | BMS-641988 | Unknown | 100 mg | Oral |